Shortages of drugs like Adderall are growing in the United States, and experts see no clear path to resolving them. For patients, that can mean treatment delays, medication switches and other hassles filling a prescription.
In recent months, unexpected demand spikes, manufacturing problems and tight ingredient supplies have contributed to shortages that stress patients, parents and doctors. For some drugs, such as stimulants that treat ADHD, several factors fueled a shortage and make it hard to predict when it will end.Shortages, particularly of generic drugs, have been a longstanding problem.
That situation seems to be improving, said University of Utah Health researcher Erin Fox. But several extended-release doses of the medication, its most popular form, remain in short supply. Injectable drugs used in hospitals and clinics, such as IV saline and some cancer treatments, are more than twice as likely as tablets or topical treatments to experience a shortage, according to a recent report written by Sen. Gary Peters, D-Mich., chairman of the Senate Committee on Homeland Security and Governmental Affairs.The Adderall manufacturing problem hit as more people started taking the drug.
“They’ve been having a run on Ozempic because people don’t want to spend that much on Wegovy,” Schondelmeyer said. “Once a shortage starts with something you make just in time anyway, it’s really hard to resolve it unless all the suppliers are back,” she said.Shortages might lead to treatment delays, which can hurt patients dealing with time-sensitive conditions like cancer.
“You can estimate you’re going to increase your production by 10%,” said Mike Ganio, senior director of pharmacy practice and quality with the American Society of Health-System Pharmacists, “but is that going to be enough?”Meanwhile, conditions that could feed future shortages still exist. The Senate report cited an overreliance on foreign sources as a concern.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
What's Behind Shortages of Adderall, Ozempic and Other Meds?Drug shortages are growing in the United States, and experts see no clear path to resolving them.
Baca lebih lajut »
What’s behind shortages of Adderall, Ozempic and other meds?Shortages of drugs like Adderall are growing in the United States, and experts see no clear path to resolving them. For patients, that can mean treatment delays, medication switches and other hassles filling a prescription.
Baca lebih lajut »
What's behind shortages of Adderall, Ozempic and other meds?The obesity drugs lower blood sugar and slow down digestion, so people feel full longer.
Baca lebih lajut »
What's behind shortages of Adderall, Ozempic and other meds?Drug shortages are growing in the United States, and experts see no clear path to resolving them. For patients, that could mean more treatment delays, medication switches and other hassles filling a prescription. That depends on the drug, some of which manufacturers have little incentive to make in large amounts because they generate thin profits. Unexpected demand spikes, manufacturing problems and tight ingredient supplies have contributed in recent months to shortages that stress patients, parents and doctors. The University of Utah Drug Information Service says there were 301 active national drug shortages through this year’s first quarter.
Baca lebih lajut »
The Adderall Shortage Is the Mental Health Crisis No One’s Talking AboutThe stigma around ADHD and therapeutic stimulants makes an already difficult situation for millions of people far worse, writes Michael A. Cohen.
Baca lebih lajut »
One in four middle, high school students with ADHD are abusing Adderall, Ritalin: studyStimulants are becoming increasingly common in the treatment of ADHD, but they rank as the most misused prescription drug among teens.
Baca lebih lajut »